Back
IT

Iambic Therapeutics,

IAM

Biotechnology · NASDAQ · IPO October 15, 2026

Biotech & Healthcare
Website unavailable

01

Company Overview

Iambic Therapeutics, is filing to list on NASDAQ Global Select. Public information at this stage is limited to the IPO calendar entry; deeper detail typically becomes available closer to pricing via the company's S-1 / prospectus.

Iambic Therapeutics, is going public on NASDAQ Global Select on 2026-10-15. Offering 9,375,000 shares.

Recent headlines

Couldn't pull live headlines right now.

02

AI Analysis

Possible growth narrative

Sits adjacent to Biotech & Healthcare — themes that are currently drawing meaningful capital and attention.

Risks

Newly public companies typically face limited operating history disclosure, lock-up expirations, and broader market sentiment swings around IPOs.

Volatility

Expect elevated price volatility in the first weeks of trading as supply and demand find balance.

Market attention

Recently listed — monitoring early trading activity and analyst initiations.

Educational summary only. Not investment advice.

03

Related Themes

Biotech & Healthcare

04

IPO Information

IPO date
October 15, 2026
Exchange
NASDAQ
Status
Recently Listed
Industry
Biotechnology
Valuation
$0.67B mkt cap
Headquarters
US
Attention score
61 / 100
Ticker
IAM